Search Results - "RASKINA, T A"

The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study by Alekseeva, L. I., Kashevarova, N. G., Taskina, E. A., Sharapova, E. P., Anikin, S. G., Strebkova, E. A., Raskina, T. A., Zonova, E. V., Otteva, E. N., Rodionova, S. S., Torgashin, A. N., Buklemishev, U. V., Shmidt, E. I., Shesternya, P. A., Naumov, A. V., Zagorodniy, N. V., Lila, A. M.

“…in 3 mL on patients with knee osteoarthritis (OA) in a multicenter prospective study. Materials and methods. 79 outpatients (predominantly females 81.0%) from…”
Get full text

Evaluation of coronary artery lesion in men with osteopenic syndrome and coronary artery disease by Kokov, A N, Maliuta, E B, Masenko, V L, Sigareva, A A, Fanaskov, V B, Tarasov, R S, Raskina, T A, Shibanova, I A, Barbarash, O L

“…To examine the relation between coronary atherosclerosis (CA), coronary artery calcification (CAC), and bone mineral density (BMD) in men with coronary artery…”
Get full text

Bone mineral density in elderly and senile women with knee and hip osteoarthritis by Averkieva, Yu. V., Grigorieva, I. I., Raskina, T. A.

“…Objective : to study bone mineral density (BMD) in elderly and senile women with knee and hip osteoarthritis (OA). Patients and methods . The investigation…”
Get full text

Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR by Mazurov, V. I., Nasonov, E. L., Lila, A. M., Korolev, M. A., Prystrom, A. M., Kundzer, E. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Plaksina, T. V., Antipova, O. V., Krechikova, D. G., Smakotina, S. A., Tciupa, O. A., Puntus, E. V., Raskina, T. A., Shilova, L. N., Kropotina, T. V., Nesmeyanova, O. B., Popova, T. A., Vinogradova, I. B., Dokukina, E. A., Plotnikova, A. V., Pukhtinskaia, P. S., Zinkina-Orikhan, A. V., Linkova, Yu. N., Eremeeva, A. V., Lutckii, A. A.

“…—Background . Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active…”
Get full text

Musculoskeletal losses in patients with ankylosing spondylitis by Raskina, T. A., Grigorieva, I. I., Malyshenko, O. S.

“…Ankylosing spondylitis (AS) is one of the most common autoinflammatory diseases that lead to early disability and high premature mortality rates. Along with…”
Get full text

Results of a prospective 6-year observational study of the efficacy and safety of a bioactive concentrate of small marine fish in senile patients with knee osteoarthritis and multimorbidity by Letaeva, M. V., Koroleva, M. V., Raskina, T. A., Malyshenko, O. S., Averkieva, Yu. V., Usova, E. V.

“…Objective : to evaluate the efficacy and safety of Alflutop therapy in elderly patients (75–90 years old) with knee osteoarthritis (OA) and multimorbidity…”
Get full text

Evaluation of the efficacy and safety of bioactive concentrate from small sea fish in elderly patients with knee osteoarthritis by Usova, E. V., Averkieva, Yu. V., Letaeva, M. V., Malyshenko, O. S., Koroleva, M. V., Raskina, T. A.

“…Objective : to evaluate the efficacy and safety of Alflutop (the bioactive concentrate from small sea fish) in patients aged 75 years and older with knee…”
Get full text

Articular syndrome in an HIV-infected patient by Malyshenko, O. S., Raskina, T. A., Averkieva, Yu. V., Protasova, T. V., Dubaeva, A. M.

“…Nowadays, HIV infection is one of the leading health problems. Its clinical signs are extremely diverse and are associated with many diseases, including…”
Get full text

Bone mineral density in patients with coronary artery disease and sarcopenia by Grigorieva, I. I., Raskina, T. A., Letaeva, M. V., Ivanov, V. I., Masenko, V. L.

“…Objective : to assess the relationship between bone mineral density (BMD) and the muscular apparatus in male patients with coronary heart disease (CHD)…”
Get full text

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR by Mazurov, V. I., Lila, A. M., Korolev, M. A., Prystrom, A. M., Kundzer, A. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Plaksina, T. V., Antipova, O. V., Krechikova, D. G., Smakotina, S. A., Tciupa, O. A., Puntus, E. V., Raskina, T. A., Shilova, L. N., Kropotina, T. V., Nesmeyanova, O. B., Popova, T. A., Vinogradova, I. B., Dokukina, E. A., Plotnikova, A. V., Pukhtinskaia, P. S., Zinkina-Orikhan, A. V., Linkova, Yu. N., Eremeeva, A. V., Lutckii, A. A., Nasonov, E. L.

“…Background . Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active…”
Get full text

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR) by Mazurov, V. I., Korolev, M. A., Prystrom, A. M., Kunder, E. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Plaksina, T. V., Antipova, O. V., Kretchikova, D. G., Smakotina, S. A., Tciupa, O. A., Puntus, E. V., Raskina, T. A., Shilova, L. N., Kropotina, T. V., Nesmeyanova, O. B., Popova, T. A., Vinogradova, I. B., Linkova, Yu. N., Dokukina, E. A., Plotnikova, A. V., Pukhtinskaia, P. S., Zinkina-Orikhan, A. V., Eremeeva, A. V., Lutckii, A. A.

“…Levilimab is anti-interleukin-6 receptor (IL6R) monoclonal antibody. The article presents data obtained during 24 weeks of the SOLAR phase III study. Objective…”
Get full text

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study by Alekseeva, L. I., Taskina, E. A., Kashevarova, N. G., Sharapova, E. P., Strebkova, E. A., Anikin, S. G., Chichasova, N. V., Raskina, T. A., Zonova, E. V., Otteva, E. N., Shmidt, E. I., Yakupova, S. P., Vinogradova, I. B., Ivanova, O. N., Lila, V. A., Zavadovsky, B. V., Shesternya, P. A., Lila, A. M.

“…Objective : to evaluate the efficacy and safety of glycosaminoglycan-peptide complex (GPC, Rumalon) used in patients with knee osteoarthritis (OA) and…”
Get full text

Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting by Lila, A. M., Alekseeva, L. I., Babaeva, A. R., Gaydukova, I. Z., Gandolini, G., Zonova, E. V., Capelli, R., Karateev, A. E., Kopenkin, S. S., Martusevich, N. A., Nesmeyanova, O. B., Otteva, E. N., Rannuе, F., Raskina, T. A., Sukhareva, M. L., Taskina, E. A., Chichasova, N. V., Yakupova, S. P.

“…The paper presents the results of the Osteoarthritis (OA) Expert Council held on September 8, 2019, which was attended by Russian and foreign specialists. The…”
Get full text

CHANGES OF BONE MINERAL DENSITY DURING FOUR-YEAR RITUXIMAB AND METHOTREXATE THERAPY IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS by Raskina, T. A., Koroleva, M. V., Malyshenko, O. S.

“…Objective: to estimate the changes of bone mineral density (BMD)  at the femoral neck and lumbar spine during fouryear combination  therapy with rituximab…”
Get full text

Relationship between bone remodeling markers, bone mineral density, and severity of coronary atherosclerosis in men with stable coronary heart disease by Raskina, T. A., Letaeva, M. V., Voronkina, A. V., Malyuta, E. B., Khryachkova, O. N., Barbarash, O. L.

“…The development of atherosclerosis is a complex multifactorial process, in which the markers of bone formation and resorption play an important role and which…”
Get full text

EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY by Raskina, T. A., Malyshenko, O. S., Pirogova, O. A., Volykova, M. A.

“…In accordance  with the Ankylosing Spondylitis Assessments (ASAS) International Working Group guidelines, tumor necrosis factor-α  inhibitors are recommended…”
Get full text

Sociomedical sequels and quality of life in patients of old age group with proximal femoral fractures by Raskina, T. A., Averkieva, Yu. V.

“…The sociomedical significance of osteoporosis is determined by its sequels (vertebral and peripheral skeletal fractures) that are responsible for high…”
Get full text

Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial by Erdes, Sh, Mazurov, V. I., Dubinina, T. V., Gaydukova, I. Z., Lapshina, S. A., Zonova, E. V., Krechikova, D. G., Plaksina, T. V., Reshetko, O. V., Smakotina, S. A., Shesternya, P. А., Gordeev, I. G., Makulova, T. G., Povarova, T. V., Raskina, T. A., Soroka, N. F., Pristrom, A. M., Kunder, E. V., Usacheva, Yu. V., Stukalina, E. Yu, Eremeeva, A. V., Chernyaeva, E. V., Ivanov, R. A.

“…The paper presents the results of a double-blind (BCD-085-3/AILAS) phase II clinical trial of the original interleukin 17A (IL17A) inhibitor BCD-085 prescribed…”
Get full text

Spondyloarthritis: modern terminology and definitions by Erdes, Sh F, Rebrov, A P, Dubinina, T V, Badokin, V V, Bochkova, A G, Bugrova, O V, Gaydukova, I Z, Godzenko, A A, Dubikov, A A, Ivanova, O N, Korotaeva, T V, Lapshina, S A, Nesmeyanova, O B, Nikishina, I P, Otteva, E N, Raskina, T A, Rumyantseva, O A, Sitalo, A V, Smirnov, A V

“…Aim to identify outdated terms and make changes to the terminology of spondyloarthritis. Materials and methods. At the first stage of the work, the terms…”
Get full text

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY by Alekseeva, L. I., Taskina, E. A., Kashevarova, N. G., Sharapova, E. P., Anikin, S. G., Strebkova, E. A., Korotkova, T. А., Raskina, T. A., Zonova, E. V., Otteva, E. N.

“…Objective: to investigate the effect of diacerein (Diaflex) on some components of metabolic syndrome (MS) in patients with knee osteoarthritis (OA).Subjects…”
Get full text